Geode Capital Management, LLC Cel Sci Corp Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 612,861 shares of CVM stock, worth $343,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares

612,861

Previous 558,982 9.64%

Holding current value

$343,202

Previous $648,000 0.15%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.05 - $1.5 $56,572 - $80,818	53,879 Added 9.64%	612,861 $649,000
Q2 2024 Aug 09, 2024	BUY	$1.11 - $1.85 $104,976 - $174,960	94,573 Added 20.36%	558,982 $648,000
Q1 2024 May 13, 2024	SELL	$1.63 - $3.08 $22,802 - $43,086	-13,989 Reduced 2.92%	464,409 $887,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $3.07 $22,037 - $63,229	20,596 Added 4.5%	478,398 $1.3 Million
Q3 2023 Nov 13, 2023	BUY	$1.17 - $2.86 $40,132 - $98,100	34,301 Added 8.1%	457,802 $572,000
Q2 2023 Aug 11, 2023	BUY	$2.11 - $2.83 $87,354 - $117,162	41,400 Added 10.83%	423,501 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$1.99 - $3.52 $8,051 - $14,241	4,046 Added 1.07%	382,101 $897,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $5.23 $12,245 - $20,726	3,963 Added 1.06%	378,055 $1.17 Million
Q2 2022 Aug 12, 2022	SELL	$2.58 - $4.99 $814,371 - $1.58 Million	-315,648 Reduced 45.76%	374,092 $1.68 Million
Q1 2022 May 13, 2022	BUY	$3.93 - $7.7 $197,069 - $386,116	50,145 Added 7.84%	689,740 $2.71 Million
Q4 2021 Feb 11, 2022	SELL	$7.1 - $12.82 $283,211 - $511,376	-39,889 Reduced 5.87%	639,595 $4.54 Million
Q3 2021 Nov 12, 2021	BUY	$7.64 - $12.49 $434,555 - $710,418	56,879 Added 9.14%	679,484 $7.47 Million
Q2 2021 Aug 13, 2021	BUY	$8.68 - $27.49 $121,007 - $383,238	13,941 Added 2.29%	622,605 $5.4 Million
Q1 2021 May 12, 2021	BUY	$12.0 - $27.64 $1.21 Million - $2.8 Million	101,208 Added 19.94%	608,664 $9.26 Million
Q4 2020 Feb 12, 2021	BUY	$11.05 - $16.62 $275,896 - $414,968	24,968 Added 5.17%	507,456 $5.92 Million
Q3 2020 Nov 13, 2020	BUY	$11.69 - $14.54 $131,547 - $163,618	11,253 Added 2.39%	482,488 $6.15 Million
Q2 2020 Aug 13, 2020	BUY	$9.75 - $17.6 $37,303 - $67,337	3,826 Added 0.82%	471,235 $7.03 Million
Q1 2020 May 14, 2020	BUY	$7.54 - $17.05 $649,005 - $1.47 Million	86,075 Added 22.57%	467,409 $5.39 Million
Q4 2019 Feb 13, 2020	BUY	$6.71 - $9.55 $226,415 - $322,245	33,743 Added 9.71%	381,334 $3.49 Million
Q3 2019 Nov 12, 2019	BUY	$6.0 - $9.6 $141,792 - $226,867	23,632 Added 7.29%	347,591 $3.11 Million
Q2 2019 Aug 14, 2019	BUY	$3.77 - $8.67 $763,937 - $1.76 Million	202,636 Added 167.02%	323,959 $2.71 Million
Q1 2019 May 14, 2019	BUY	$2.58 - $3.54 $17,683 - $24,263	6,854 Added 5.99%	121,323 $429,000
Q3 2018 Nov 13, 2018	BUY	$0.83 - $4.16 $24,343 - $122,012	29,330 Added 34.45%	114,469 $463,000
Q2 2018 Aug 14, 2018	BUY	$0.92 - $3.5 $43,700 - $166,250	47,500 Added 126.2%	85,139 $78,000
Q1 2018 May 15, 2018	SELL	$1.38 - $2.33 $28 - $48	-21 Reduced 0.06%	37,639 $53,000
Q2 2017 Aug 14, 2017	BUY	N/A	37,660	37,660 $83,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $24.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cel Sci Corp Transaction History